Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Tax Provisions (2016 - 2019)

IGC Pharma (IGC) has disclosed Tax Provisions for 9 consecutive years, with $2000.0 as the latest value for Q1 2019.

  • Quarterly Tax Provisions changed N/A to $2000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $2000.0 for FY2019, N/A changed from the prior year.
  • Tax Provisions for Q1 2019 was $2000.0 at IGC Pharma, up from -$1.1 million in the prior quarter.
  • The five-year high for Tax Provisions was $445000.0 in Q4 2015, with the low at -$1.4 million in Q1 2016.
  • Average Tax Provisions over 4 years is -$330826.8, with a median of $2014.5 recorded in 2015.
  • The sharpest move saw Tax Provisions soared 140.68% in 2015, then plummeted 70993.1% in 2016.
  • Over 4 years, Tax Provisions stood at $445000.0 in 2015, then crashed by 83.6% to $73000.0 in 2016, then tumbled by 1563.79% to -$1.1 million in 2017, then surged by 100.19% to $2000.0 in 2019.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $2000.0, -$1.1 million, and $73000.0 for Q1 2019, Q1 2017, and Q4 2016 respectively.